Ubrelvy 100 MG tablet UD 16S
Ended Awarded Last action
- Contract number
- SPE2DR26F9CMH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,881
Award facts
- Contract value 100% obligated
- $1,880.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,880.85 to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (16 unit dose packs) on January 2, 2026, with a completion date of January 5, 2026. This is a firm fixed-price, non-set-aside delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 and extends through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
UBRELVY (ubrogepant) is a calcitonin gene-related peptide receptor antagonist used for acute migraine treatment. This delivery order represents a routine pharmaceutical supply requirement under AmerisourceBergen's comprehensive global pharmaceutical support agreement with DLA, which enables the company to supply a broad range of medications and medical supplies to support military healthcare programs and the Defense Health Agency. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen regularly fulfills such delivery orders for brand-name and generic drugs, vaccines, and specialized medical commodities across multiple therapeutic domains for military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9CMH?
SPE2DR26F9CMH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 2, 2026.
How much is contract SPE2DR26F9CMH worth?
The government has obligated $1,881 on SPE2DR26F9CMH.
Is contract SPE2DR26F9CMH an order under another contract?
Yes. SPE2DR26F9CMH is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9CMH competed?
The extent of competition for SPE2DR26F9CMH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award